Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:37796506

Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.

Miquel Ensenyat-Mendez · Maria Solivellas-Pieras · Pere Llinàs-Arias · Sandra Íñiguez-Muñoz · Jennifer L Baker · Diego M Marzese · Maggie L DiNome

JAMA network open · 2023 doi:10.1001/jamanetworkopen.2023.35821

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:37796506
kind
science-record
content_hash
sha256:3a637e925e395e6a70275f6d0c6a111b0eff2a3dbd11f164e49f14c3e31c8dc5
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T19:02:39Z
updated_at
2026-11-01T22:10:25Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.
doi
10.1001/jamanetworkopen.2023.35821
pmid
37796506
authors array · 7 items
[0]
Miquel Ensenyat-Mendez
[1]
Maria Solivellas-Pieras
[2]
Pere Llinàs-Arias
[3]
Sandra Íñiguez-Muñoz
[4]
Jennifer L Baker
[5]
Diego M Marzese
[6]
Maggie L DiNome
journal
JAMA network open
year
2023
abstract
Importance: Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and appears to have disproportionately higher incidence and worse outcomes among younger African American females. Objective: To investigate whether epigenetic differences exist in TNBCs of younger African American females that may explain clinical disparities seen in this patient group. Design, Setting, and Participants: This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021. White and African American females with TNBC identified in TCGA (69 patients) and a validation cohort of 210 African American patients from GEO (GSE142102) were included. Patients without available race or age data were excluded. Data were analyzed from September 2022 through April 2023. Main Outcomes and Measures: DNA methylation and gene expression profiles of TNBC tumors by race (self-reported) and age were assessed. Age was considered a dichotomous variable using age 50 years as the cutoff (younger [<50 years] vs older [≥50 years]). Results: A total of 69 female patients (34 African American [49.3%] and 35 White [50.7%]; mean [SD; range] age, 55.7 [11.6; 29-82] years) with TNBC were included in the DNA methylation analysis; these patients and 210 patients in the validation cohort were included in the gene expression analysis (279 patients). There were 1115 differentially methylated sites among younger African American females. The DNA methylation landscape on TNBC tumors in this population had increased odds of enrichment of hormone (odds ratio [OR], 1.82; 95% CI, 1.21 to 2.67; P = .003), muscle (OR, 1.85; 95% CI, 1.44 to 2.36; P < .001), and proliferation (OR, 3.14; 95% CI, 2.71 to 3.64; P < .001) pathways vs other groups (older African American females and all White females). Alterations in regulators of these molecular features in TNBCs of younger African American females were identified involving hormone modulation (downregulation of androgen receptor: fold change [FC] = -2.93; 95% CI, -4.76 to -2.11; P < .001) and upregulation of estrogen-related receptor α (FC = 0.86; 95% CI, 0.34 to 1.38; P = .002), muscle metabolism (upregulation of FOXC1: FC = 1.33; 95% CI, 0.62 to 2.03; P < .001), and proliferation mediators (upregulation of NOTCH1: FC = 0.71; 95% CI, 0.23 to 1.19; P = .004 and MYC (FC = 0.81; 95% CI, 0.18 to 1.45; P = .01). Conclusions and Relevance: These findings suggest that TNBC of younger African American females may represent a distinct epigenetic entity and offer novel insight into molecular alterations associated with TNBCs of this population. Understanding these epigenetic differences may lead to the development of more effective therapies for younger African American females, who have the highest incidence and worst outcomes from TNBC of any patient group.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Differentially methylated sites (DMSs) were computed using the Wilcoxon test.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37796506
locator
sections[4] "Statistical Analysis" paragraph 3
quote
Differentially methylated sites (DMSs) were computed using the Wilcoxon test.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37796506
locator
sections[0] "Abstract" paragraph 7
quote
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
state
complete
[2] object · 6 fields
id
claim-target-result
statement
In a cross-sectional study of 69 female patients with TNBC, tumors of younger African American patients had a distinct DNA methylation profile compared with those of older African American females and White females of all ages.
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:37796506
locator
sections[0] "Abstract" paragraph 3
quote
In this cross-sectional study of 69 female patients with TNBC, tumors of younger African American patients had a distinct DNA methylation profile compared with those of older African American females and White females of all ages.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
In a cross-sectional study of 69 female patients with TNBC, tumors of younger African American patients had a distinct DNA methylation profile compared with those of older African American females and White females of all ages.
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:37796506
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE142102
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:group_comparison_wilcoxon
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE142102
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:run_analysis blocked on method:group_comparison_wilcoxon
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:37796506
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1001/jamanetworkopen.2023.35821
sha256
sha256:a90929ac1b8d41f58554bab968c8a78e4ee9144590bc86f4424d7bbf62e2851e
bytes
44733
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1001/jamanetworkopen.2023.35821
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC10556970
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE142102
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142102
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE142102
version
null
note
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
access_statement_kind
repository_route_statement
sample_accessions array · 226 items
[0]
GSM4220614
[1]
GSM4220615
[2]
GSM4220616
[3]
GSM4220617
[4]
GSM4220618
[5]
GSM4220619
[6]
GSM4220620
[7]
GSM4220621
[8]
GSM4220622
[9]
GSM4220623
[10]
GSM4220624
[11]
GSM4220625
[12]
GSM4220626
[13]
GSM4220627
[14]
GSM4220628
[15]
GSM4220629
[16]
GSM4220630
[17]
GSM4220631
[18]
GSM4220632
[19]
GSM4220633
[20]
GSM4220634
[21]
GSM4220635
[22]
GSM4220636
[23]
GSM4220637
[24]
GSM4220638
[25]
GSM4220639
[26]
GSM4220640
[27]
GSM4220641
[28]
GSM4220642
[29]
GSM4220643
[30]
GSM4220644
[31]
GSM4220645
[32]
GSM4220646
[33]
GSM4220647
[34]
GSM4220648
[35]
GSM4220649
[36]
GSM4220650
[37]
GSM4220651
[38]
GSM4220652
[39]
GSM4220653
[40]
GSM4220654
[41]
GSM4220655
[42]
GSM4220656
[43]
GSM4220657
[44]
GSM4220658
[45]
GSM4220659
[46]
GSM4220660
[47]
GSM4220661
[48]
GSM4220662
[49]
GSM4220663
[50]
GSM4220664
[51]
GSM4220665
[52]
GSM4220666
[53]
GSM4220667
[54]
GSM4220668
[55]
GSM4220669
[56]
GSM4220670
[57]
GSM4220671
[58]
GSM4220672
[59]
GSM4220673
[60]
GSM4220674
[61]
GSM4220675
[62]
GSM4220676
[63]
GSM4220677
[64]
GSM4220678
[65]
GSM4220679
[66]
GSM4220680
[67]
GSM4220681
[68]
GSM4220682
[69]
GSM4220683
[70]
GSM4220684
[71]
GSM4220685
[72]
GSM4220686
[73]
GSM4220687
[74]
GSM4220688
[75]
GSM4220689
[76]
GSM4220690
[77]
GSM4220691
[78]
GSM4220692
[79]
GSM4220693
[80]
GSM4220694
[81]
GSM4220695
[82]
GSM4220696
[83]
GSM4220697
[84]
GSM4220698
[85]
GSM4220699
[86]
GSM4220700
[87]
GSM4220701
[88]
GSM4220702
[89]
GSM4220703
[90]
GSM4220704
[91]
GSM4220705
[92]
GSM4220706
[93]
GSM4220707
[94]
GSM4220708
[95]
GSM4220709
[96]
GSM4220710
[97]
GSM4220711
[98]
GSM4220712
[99]
GSM4220713
[100]
GSM4220714
[101]
GSM4220715
[102]
GSM4220716
[103]
GSM4220717
[104]
GSM4220718
[105]
GSM4220719
[106]
GSM4220720
[107]
GSM4220721
[108]
GSM4220722
[109]
GSM4220723
[110]
GSM4220724
[111]
GSM4220725
[112]
GSM4220726
[113]
GSM4220727
[114]
GSM4220728
[115]
GSM4220729
[116]
GSM4220730
[117]
GSM4220731
[118]
GSM4220732
[119]
GSM4220733
[120]
GSM4220734
[121]
GSM4220735
[122]
GSM4220736
[123]
GSM4220737
[124]
GSM4220738
[125]
GSM4220739
[126]
GSM4220740
[127]
GSM4220741
[128]
GSM4220742
[129]
GSM4220743
[130]
GSM4220744
[131]
GSM4220745
[132]
GSM4220746
[133]
GSM4220747
[134]
GSM4220748
[135]
GSM4220749
[136]
GSM4220750
[137]
GSM4220751
[138]
GSM4220752
[139]
GSM4220753
[140]
GSM4220754
[141]
GSM4220755
[142]
GSM4220756
[143]
GSM4220757
[144]
GSM4220758
[145]
GSM4220759
[146]
GSM4220760
[147]
GSM4220761
[148]
GSM4220762
[149]
GSM4220763
[150]
GSM4220764
[151]
GSM4220765
[152]
GSM4220766
[153]
GSM4220767
[154]
GSM4220768
[155]
GSM4220769
[156]
GSM4220770
[157]
GSM4220771
[158]
GSM4220772
[159]
GSM4220773
[160]
GSM4220774
[161]
GSM4220775
[162]
GSM4220776
[163]
GSM4220777
[164]
GSM4220779
[165]
GSM4220782
[166]
GSM4220784
[167]
GSM4220786
[168]
GSM4220787
[169]
GSM4220788
[170]
GSM4220789
[171]
GSM4220790
[172]
GSM4220791
[173]
GSM4220792
[174]
GSM4220793
[175]
GSM4220794
[176]
GSM4220795
[177]
GSM4220796
[178]
GSM4220797
[179]
GSM4220798
[180]
GSM4220799
[181]
GSM4220800
[182]
GSM4220801
[183]
GSM4220802
[184]
GSM4220803
[185]
GSM4220804
[186]
GSM4220805
[187]
GSM4220806
[188]
GSM4220807
[189]
GSM4220808
[190]
GSM4220809
[191]
GSM4220810
[192]
GSM4220811
[193]
GSM4220812
[194]
GSM4220813
[195]
GSM4220814
[196]
GSM4220815
[197]
GSM4220816
[198]
GSM4220817
[199]
GSM4220818
[200]
GSM4220819
[201]
GSM4220820
[202]
GSM4220821
[203]
GSM4220822
[204]
GSM4220823
[205]
GSM4220824
[206]
GSM4220825
[207]
GSM4220826
[208]
GSM4220827
[209]
GSM4220828
[210]
GSM4220829
[211]
GSM4220830
[212]
GSM4220831
[213]
GSM4220832
[214]
GSM4220833
[215]
GSM4220834
[216]
GSM4220835
[217]
GSM4220836
[218]
GSM4220837
[219]
GSM4220838
[220]
GSM4220839
[221]
GSM4220840
[222]
GSM4220841
[223]
GSM4220842
[224]
GSM4220843
[225]
GSM4220844
sample_count
226
group_sizes
null
group_sizes_basis
null
platform
17692
taxon
Homo sapiens
title
Whole genome expression profiling of triple negative breast tumors in 226 African American women
resolution_checked_at
2026-11-01T19:09:46Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE83860
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83860
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE83860
version
null
note
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
access_statement_kind
repository_route_statement
sample_accessions array · 46 items
[0]
GSM2219848
[1]
GSM2219849
[2]
GSM2219850
[3]
GSM2219851
[4]
GSM2219852
[5]
GSM2219853
[6]
GSM2219854
[7]
GSM2219855
[8]
GSM2219856
[9]
GSM2219857
[10]
GSM2219858
[11]
GSM2219859
[12]
GSM2219860
[13]
GSM2219861
[14]
GSM2219862
[15]
GSM2219863
[16]
GSM2219864
[17]
GSM2219865
[18]
GSM2219866
[19]
GSM2219867
[20]
GSM2219868
[21]
GSM2219869
[22]
GSM2219870
[23]
GSM2219871
[24]
GSM2219872
[25]
GSM2219873
[26]
GSM2219874
[27]
GSM2219875
[28]
GSM2219876
[29]
GSM2219877
[30]
GSM2219878
[31]
GSM2219879
[32]
GSM2219880
[33]
GSM2219881
[34]
GSM2219882
[35]
GSM2219883
[36]
GSM2219884
[37]
GSM2219885
[38]
GSM2219886
[39]
GSM2219887
[40]
GSM2219888
[41]
GSM2219889
[42]
GSM2219890
[43]
GSM2219891
[44]
GSM2219892
[45]
GSM2219893
sample_count
46
group_sizes
null
group_sizes_basis
null
platform
11154
taxon
Homo sapiens
title
Crosstalk between androgen and proinflammatory signaling activates a distinct transcription program in prostate cancer cells
resolution_checked_at
2026-11-01T19:09:46Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 4 items
[0]
asset:data:geo:GSE142102 not downloaded
[1]
asset:data:geo:GSE142102 licence not read
[2]
asset:data:geo:GSE83860 not downloaded
[3]
asset:data:geo:GSE83860 licence not read
analysis object · 4 fields
state
partial
methods array · 4 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
wilcoxon
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
verbatim
quote
Differentially methylated sites (DMSs) were computed using the Wilcoxon test.
[1] object · 10 fields
id
method-2
family
clustering
specific
hierarchical
label
Clustering
dsl_operations array · 1 item
[0]
hierarchical_cluster
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
feature_matrix
evidence object · 3 fields
score
0.8
band
high
quote
hierarchical clustering
[2] object · 10 fields
id
method-3
family
network_analysis
specific
pathway_enrichment
label
Network / pathway analysis
dsl_operations array · 1 item
[0]
pathway_enrich
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
edge_list
evidence object · 3 fields
score
0.8
band
high
quote
Pathway enrichment
[3] object · 10 fields
id
method-4
family
contingency_analysis
specific
chi_square
label
Categorical (contingency table) analysis
dsl_operations array · 1 item
[0]
chi_square_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
categorical_cross_tabulation
evidence object · 3 fields
score
0.8
band
high
quote
χ2
targets array · 0 items
gaps array · 1 item
[0]
method.group_comparison_wilcoxon
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE142102
[1]
GSE83860
resolved_accessions array · 2 items
[0]
GSE142102
[1]
GSE83860
statements array · 1 item
[0]
This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.
basis
The paper names GSE142102, GSE83860 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:37796506
[1]
data:geo:GSE142102
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
group_comparison_wilcoxon
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE142102
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T18:55:14Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
null
calls
5
usage object · 3 fields
prompt_tokens
12647
completion_tokens
2083
cached_tokens
128
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:37796506
type
paper
label
pmid:37796506
[1] object · 3 fields
id
source:pmid:37796506
type
manuscript
label
PMID 37796506 full text
[2] object · 3 fields
id
data:geo:GSE142102
type
dataset
label
GEO GSE142102
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:37796506
type
paper
label
pmid:37796506
[1] object · 3 fields
id
source:pmid:37796506
type
manuscript
label
PMID 37796506 full text
[2] object · 3 fields
id
data:geo:GSE142102
type
dataset
label
GEO GSE142102
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-37796506
type
extraction
used array · 1 item
[0]
source:pmid:37796506
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE142102
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE142102
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:37796506
parent_hash
sha256:f68ff4d8bb3b12c8fba58e08ddc41f3958a86c191263886c657ba118cf9846c5
fork_of
null
gaps array · 10 items
[0]
asset:data:geo:GSE142102 licence not read
[1]
asset:data:geo:GSE142102 not downloaded
[2]
asset:data:geo:GSE83860 licence not read
[3]
asset:data:geo:GSE83860 not downloaded
[4]
execution.not_run
[5]
method.group_comparison_wilcoxon
[6]
review.human_critique
[7]
review.independent_reader
[8]
review.machine_critique
[9]
step:run_analysis blocked on method:group_comparison_wilcoxon
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
rna_seq
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
hylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from public
[1]
netic regulation in maintaining the specific transcriptome of TNBCs of younger African American patient
[2]
(Figure 3D), suggesting that epigenetic and transcriptomic alterations in hormone, muscle, and prolifer
order_basis
paper_text_order:591
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Differentially methylated sites (DMSs) were computed using the Wilcoxon test.
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:37796506", "kind": "science-record", "revision": 4, "content_hash": "sha256:3a637e925e395e6a70275f6d0c6a111b0eff2a3dbd11f164e49f14c3e31c8dc5", "created_at": "2026-11-01T19:02:39Z", "updated_at": "2026-11-01T22:10:25Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Epigenetic Profiles of Triple-Negative Breast Cancers of African American and White Females.", "doi": "10.1001/jamanetworkopen.2023.35821", "pmid": "37796506", "authors": ["Miquel Ensenyat-Mendez", "Maria Solivellas-Pieras", "Pere Llinàs-Arias", "Sandra Íñiguez-Muñoz", "Jennifer L Baker", "Diego M Marzese", "Maggie L DiNome"], "journal": "JAMA network open", "year": 2023, "abstract": "Importance: Triple-negative breast cancer (TNBC) is the most aggressive breast cancer subtype and appears to have disproportionately higher incidence and worse outcomes among younger African American females.\nObjective: To investigate whether epigenetic differences exist in TNBCs of younger African American females that may explain clinical disparities seen in this patient group.\nDesign, Setting, and Participants: This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021. White and African American females with TNBC identified in TCGA (69 patients) and a validation cohort of 210 African American patients from GEO (GSE142102) were included. Patients without available race or age data were excluded. Data were analyzed from September 2022 through April 2023.\nMain Outcomes and Measures: DNA methylation and gene expression profiles of TNBC tumors by race (self-reported) and age were assessed. Age was considered a dichotomous variable using age 50 years as the cutoff (younger [<50 years] vs older [≥50 years]).\nResults: A total of 69 female patients (34 African American [49.3%] and 35 White [50.7%]; mean [SD; range] age, 55.7 [11.6; 29-82] years) with TNBC were included in the DNA methylation analysis; these patients and 210 patients in the validation cohort were included in the gene expression analysis (279 patients). There were 1115 differentially methylated sites among younger African American females. The DNA methylation landscape on TNBC tumors in this population had increased odds of enrichment of hormone (odds ratio [OR], 1.82; 95% CI, 1.21 to 2.67; P = .003), muscle (OR, 1.85; 95% CI, 1.44 to 2.36; P < .001), and proliferation (OR, 3.14; 95% CI, 2.71 to 3.64; P < .001) pathways vs other groups (older African American females and all White females). Alterations in regulators of these molecular features in TNBCs of younger African American females were identified involving hormone modulation (downregulation of androgen receptor: fold change [FC] = -2.93; 95% CI, -4.76 to -2.11; P < .001) and upregulation of estrogen-related receptor α (FC = 0.86; 95% CI, 0.34 to 1.38; P = .002), muscle metabolism (upregulation of FOXC1: FC = 1.33; 95% CI, 0.62 to 2.03; P < .001), and proliferation mediators (upregulation of NOTCH1: FC = 0.71; 95% CI, 0.23 to 1.19; P = .004 and MYC (FC = 0.81; 95% CI, 0.18 to 1.45; P = .01).\nConclusions and Relevance: These findings suggest that TNBC of younger African American females may represent a distinct epigenetic entity and offer novel insight into molecular alterations associated with TNBCs of this population. Understanding these epigenetic differences may lead to the development of more effective therapies for younger African American females, who have the highest incidence and worst outcomes from TNBC of any patient group.", "claims": [{"id": "claim-method", "statement": "Differentially methylated sites (DMSs) were computed using the Wilcoxon test.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:37796506", "locator": "sections[4] \"Statistical Analysis\" paragraph 3", "quote": "Differentially methylated sites (DMSs) were computed using the Wilcoxon test."}], "state": "complete"}, {"id": "claim-data-access", "statement": "This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:37796506", "locator": "sections[0] \"Abstract\" paragraph 7", "quote": "This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021."}], "state": "complete"}, {"id": "claim-target-result", "statement": "In a cross-sectional study of 69 female patients with TNBC, tumors of younger African American patients had a distinct DNA methylation profile compared with those of older African American females and White females of all ages.", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:37796506", "locator": "sections[0] \"Abstract\" paragraph 3", "quote": "In this cross-sectional study of 69 female patients with TNBC, tumors of younger African American patients had a distinct DNA methylation profile compared with those of older African American females and White females of all ages."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "In a cross-sectional study of 69 female patients with TNBC, tumors of younger African American patients had a distinct DNA methylation profile compared with those of older African American females and White females of all ages.", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:37796506"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE142102"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:group_comparison_wilcoxon", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE142102"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:group_comparison_wilcoxon"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:37796506", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1001/jamanetworkopen.2023.35821", "sha256": "sha256:a90929ac1b8d41f58554bab968c8a78e4ee9144590bc86f4424d7bbf62e2851e", "bytes": 44733, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1001/jamanetworkopen.2023.35821", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC10556970", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE142102", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE142102", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE142102", "version": null, "note": "This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM4220614", "GSM4220615", "GSM4220616", "GSM4220617", "GSM4220618", "GSM4220619", "GSM4220620", "GSM4220621", "GSM4220622", "GSM4220623", "GSM4220624", "GSM4220625", "GSM4220626", "GSM4220627", "GSM4220628", "GSM4220629", "GSM4220630", "GSM4220631", "GSM4220632", "GSM4220633", "GSM4220634", "GSM4220635", "GSM4220636", "GSM4220637", "GSM4220638", "GSM4220639", "GSM4220640", "GSM4220641", "GSM4220642", "GSM4220643", "GSM4220644", "GSM4220645", "GSM4220646", "GSM4220647", "GSM4220648", "GSM4220649", "GSM4220650", "GSM4220651", "GSM4220652", "GSM4220653", "GSM4220654", "GSM4220655", "GSM4220656", "GSM4220657", "GSM4220658", "GSM4220659", "GSM4220660", "GSM4220661", "GSM4220662", "GSM4220663", "GSM4220664", "GSM4220665", "GSM4220666", "GSM4220667", "GSM4220668", "GSM4220669", "GSM4220670", "GSM4220671", "GSM4220672", "GSM4220673", "GSM4220674", "GSM4220675", "GSM4220676", "GSM4220677", "GSM4220678", "GSM4220679", "GSM4220680", "GSM4220681", "GSM4220682", "GSM4220683", "GSM4220684", "GSM4220685", "GSM4220686", "GSM4220687", "GSM4220688", "GSM4220689", "GSM4220690", "GSM4220691", "GSM4220692", "GSM4220693", "GSM4220694", "GSM4220695", "GSM4220696", "GSM4220697", "GSM4220698", "GSM4220699", "GSM4220700", "GSM4220701", "GSM4220702", "GSM4220703", "GSM4220704", "GSM4220705", "GSM4220706", "GSM4220707", "GSM4220708", "GSM4220709", "GSM4220710", "GSM4220711", "GSM4220712", "GSM4220713", "GSM4220714", "GSM4220715", "GSM4220716", "GSM4220717", "GSM4220718", "GSM4220719", "GSM4220720", "GSM4220721", "GSM4220722", "GSM4220723", "GSM4220724", "GSM4220725", "GSM4220726", "GSM4220727", "GSM4220728", "GSM4220729", "GSM4220730", "GSM4220731", "GSM4220732", "GSM4220733", "GSM4220734", "GSM4220735", "GSM4220736", "GSM4220737", "GSM4220738", "GSM4220739", "GSM4220740", "GSM4220741", "GSM4220742", "GSM4220743", "GSM4220744", "GSM4220745", "GSM4220746", "GSM4220747", "GSM4220748", "GSM4220749", "GSM4220750", "GSM4220751", "GSM4220752", "GSM4220753", "GSM4220754", "GSM4220755", "GSM4220756", "GSM4220757", "GSM4220758", "GSM4220759", "GSM4220760", "GSM4220761", "GSM4220762", "GSM4220763", "GSM4220764", "GSM4220765", "GSM4220766", "GSM4220767", "GSM4220768", "GSM4220769", "GSM4220770", "GSM4220771", "GSM4220772", "GSM4220773", "GSM4220774", "GSM4220775", "GSM4220776", "GSM4220777", "GSM4220779", "GSM4220782", "GSM4220784", "GSM4220786", "GSM4220787", "GSM4220788", "GSM4220789", "GSM4220790", "GSM4220791", "GSM4220792", "GSM4220793", "GSM4220794", "GSM4220795", "GSM4220796", "GSM4220797", "GSM4220798", "GSM4220799", "GSM4220800", "GSM4220801", "GSM4220802", "GSM4220803", "GSM4220804", "GSM4220805", "GSM4220806", "GSM4220807", "GSM4220808", "GSM4220809", "GSM4220810", "GSM4220811", "GSM4220812", "GSM4220813", "GSM4220814", "GSM4220815", "GSM4220816", "GSM4220817", "GSM4220818", "GSM4220819", "GSM4220820", "GSM4220821", "GSM4220822", "GSM4220823", "GSM4220824", "GSM4220825", "GSM4220826", "GSM4220827", "GSM4220828", "GSM4220829", "GSM4220830", "GSM4220831", "GSM4220832", "GSM4220833", "GSM4220834", "GSM4220835", "GSM4220836", "GSM4220837", "GSM4220838", "GSM4220839", "GSM4220840", "GSM4220841", "GSM4220842", "GSM4220843", "GSM4220844"], "sample_count": 226, "group_sizes": null, "group_sizes_basis": null, "platform": "17692", "taxon": "Homo sapiens", "title": "Whole genome expression profiling of triple negative breast tumors in 226 African American women", "resolution_checked_at": "2026-11-01T19:09:46Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE83860", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE83860", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE83860", "version": null, "note": "This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM2219848", "GSM2219849", "GSM2219850", "GSM2219851", "GSM2219852", "GSM2219853", "GSM2219854", "GSM2219855", "GSM2219856", "GSM2219857", "GSM2219858", "GSM2219859", "GSM2219860", "GSM2219861", "GSM2219862", "GSM2219863", "GSM2219864", "GSM2219865", "GSM2219866", "GSM2219867", "GSM2219868", "GSM2219869", "GSM2219870", "GSM2219871", "GSM2219872", "GSM2219873", "GSM2219874", "GSM2219875", "GSM2219876", "GSM2219877", "GSM2219878", "GSM2219879", "GSM2219880", "GSM2219881", "GSM2219882", "GSM2219883", "GSM2219884", "GSM2219885", "GSM2219886", "GSM2219887", "GSM2219888", "GSM2219889", "GSM2219890", "GSM2219891", "GSM2219892", "GSM2219893"], "sample_count": 46, "group_sizes": null, "group_sizes_basis": null, "platform": "11154", "taxon": "Homo sapiens", "title": "Crosstalk between androgen and proinflammatory signaling activates a distinct transcription program in prostate cancer cells", "resolution_checked_at": "2026-11-01T19:09:46Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE142102 not downloaded", "asset:data:geo:GSE142102 licence not read", "asset:data:geo:GSE83860 not downloaded", "asset:data:geo:GSE83860 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Differentially methylated sites (DMSs) were computed using the Wilcoxon test."}}, {"id": "method-2", "family": "clustering", "specific": "hierarchical", "label": "Clustering", "dsl_operations": ["hierarchical_cluster"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["feature_matrix"], "evidence": {"score": 0.8, "band": "high", "quote": "hierarchical clustering"}}, {"id": "method-3", "family": "network_analysis", "specific": "pathway_enrichment", "label": "Network / pathway analysis", "dsl_operations": ["pathway_enrich"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["edge_list"], "evidence": {"score": 0.8, "band": "high", "quote": "Pathway enrichment"}}, {"id": "method-4", "family": "contingency_analysis", "specific": "chi_square", "label": "Categorical (contingency table) analysis", "dsl_operations": ["chi_square_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["categorical_cross_tabulation"], "evidence": {"score": 0.8, "band": "high", "quote": "χ2"}}], "targets": [], "gaps": ["method.group_comparison_wilcoxon"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE142102", "GSE83860"], "resolved_accessions": ["GSE142102", "GSE83860"], "statements": ["This cross-sectional study used clinical, demographic, DNA methylation (HumanMethylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from publicly available data repositories (The Cancer Genome Atlas [TCGA], 2006-2012, and Gene Expression Omnibus [GEO], 2004-2013) accessed on April 13, 2021."], "basis": "The paper names GSE142102, GSE83860 in Gene Expression Omnibus (GEO) and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:37796506", "data:geo:GSE142102"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "group_comparison_wilcoxon", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE142102"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T18:55:14Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": null}, "calls": 5, "usage": {"prompt_tokens": 12647, "completion_tokens": 2083, "cached_tokens": 128}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:37796506", "type": "paper", "label": "pmid:37796506"}, {"id": "source:pmid:37796506", "type": "manuscript", "label": "PMID 37796506 full text"}, {"id": "data:geo:GSE142102", "type": "dataset", "label": "GEO GSE142102"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:37796506", "type": "paper", "label": "pmid:37796506"}, {"id": "source:pmid:37796506", "type": "manuscript", "label": "PMID 37796506 full text"}, {"id": "data:geo:GSE142102", "type": "dataset", "label": "GEO GSE142102"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-37796506", "type": "extraction", "used": ["source:pmid:37796506"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE142102", "type": "accession_resolution", "used": ["data:geo:GSE142102"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:37796506", "parent_hash": "sha256:f68ff4d8bb3b12c8fba58e08ddc41f3958a86c191263886c657ba118cf9846c5", "fork_of": null, "generation": 3}, "gaps": ["asset:data:geo:GSE142102 licence not read", "asset:data:geo:GSE142102 not downloaded", "asset:data:geo:GSE83860 licence not read", "asset:data:geo:GSE83860 not downloaded", "execution.not_run", "method.group_comparison_wilcoxon", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:group_comparison_wilcoxon"], "assays": [{"role": "data_generation", "definition_id": "rna_seq", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["hylation450; Illumina), and gene expression (RNA sequencing) data for US patient populations from public", "netic regulation in maintaining the specific transcriptome of TNBCs of younger African American patient", "(Figure 3D), suggesting that epigenetic and transcriptomic alterations in hormone, muscle, and prolifer"], "order_basis": "paper_text_order:591", "id": "assay:1"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Differentially methylated sites (DMSs) were computed using the Wilcoxon test."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}